Clinical Trials Directory

Trials / Unknown

UnknownNCT03469115

New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
13 Years – 17 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to find out if there is a connection between a higher level of peptide alpha defensin in blood serum with the metabolic profile of adolescents aged 13-17.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSerum bloodSerum blood test for laboratory analysis to determine level of alpha defensin

Timeline

Start date
2018-03-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2018-03-19
Last updated
2018-03-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03469115. Inclusion in this directory is not an endorsement.